ARCHIVES

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors Consider Asking DRG For Section On Prevention & Control

May 14, 1993

RFA For Patient Compliance Study

September 26, 1980

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

In Brief: GM awards Shared By Six Scientists; Pollard Named President of Salk Institute

June 21, 1996

NCI Forms Task Force To Examine Marin County Breast Cancer Incidence

November 15, 2002

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

October 15, 1976